par Piccart-Gebhart, Martine 
;Lohrisch, C;Di Leo, Angelo ;Larsimont, Denis
Référence Oncology, 61 Suppl 2, page (73-82)
Publication Publié, 2001
;Lohrisch, C;Di Leo, Angelo ;Larsimont, Denis Référence Oncology, 61 Suppl 2, page (73-82)
Publication Publié, 2001
Article révisé par les pairs
| Titre: |
|
| Auteur: | Piccart-Gebhart, Martine; Lohrisch, C; Di Leo, Angelo; Larsimont, Denis |
| Informations sur la publication: | Oncology, 61 Suppl 2, page (73-82) |
| Statut de publication: | Publié, 2001 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Algorithms |
| Antibiotics, Antineoplastic -- administration & dosage | |
| Antibodies, Monoclonal -- administration & dosage | |
| Antibodies, Monoclonal -- therapeutic use | |
| Antineoplastic Agents -- therapeutic use | |
| Antineoplastic Agents, Hormonal -- contraindications | |
| Antineoplastic Agents, Hormonal -- therapeutic use | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- chemistry | |
| Breast Neoplasms -- genetics | |
| Breast Neoplasms -- mortality | |
| Chemotherapy, Adjuvant | |
| Clinical Trials as Topic | |
| Disease Progression | |
| Drug Resistance, Multiple | |
| Drug Resistance, Neoplasm | |
| Female | |
| Genes, erbB-2 | |
| Humans | |
| Neoplasm Metastasis | |
| Neoplasm Proteins -- analysis | |
| Neoplasm Proteins -- genetics | |
| Predictive Value of Tests | |
| Prospective Studies | |
| Randomized Controlled Trials as Topic | |
| Receptor, erbB-2 -- analysis | |
| Receptors, Estrogen -- analysis | |
| Retrospective Studies | |
| Risk | |
| Survival Analysis | |
| Tamoxifen -- contraindications | |
| Tamoxifen -- therapeutic use | |
| Treatment Outcome | |
| Tumor Markers, Biological -- analysis | |
| Tumor Markers, Biological -- genetics | |
| Note générale: | Comparative Study |
| Journal Article | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0030-2414 |
| info:pii/ocl1b073 | |
| info:pmid/11694791 |
